Worldwide Clinical Trials
Buying intent
88 tracked signals | Top 15 topics are below | Marketing and Operations are carrying most of it.
Attention by team
LinkedIn activity, by teamWhere Worldwide Clinical Trials's own people are actually spending their attention, by team, by topic. Bands run Low to High against the busiest pairing on this page, and each cell also shows how much of that team's own activity it represents.
Topics being researched
30-day windowEvery tracked topic, ranked by volume, not by our guess at what matters. Confidence is the classifier's own certainty that a signal belongs where we've filed it.
3d ago
3d ago
today
today
11d ago
9d ago
9d ago
8d ago
10d ago
18d ago
4d ago
15d ago
14d ago
3d ago
11d ago
Need intent for a specific topic or industry?
We track the full taxonomy across every account in the graph — including themes not shown on this page.
Who's active at Worldwide Clinical Trials
verified title on fileTitles, seniority and topic straight from each person's own activity, with a LinkedIn link so you can check any of them yourself.
See everyone, not just the first 10
23 people across every department at Worldwide Clinical Trials, plus a LinkedIn profile link for each.
Primary products / business lines
LinkedIn company profileWorldwide Clinical Trials (Worldwide) is a global CRO serving development-driven biopharmaceutical companies, with more than 4,400 professionals operating across more than 70 countries. The company delivers therapeutically dedicated expertise in neuroscience, oncology, rare disease, and internal medicine, with comprehensive support across every development phase – from early-stage and first-in-hum
New capability sought
Employee posts (LinkedIn)Gene Therapy; Leadership Development; Oncology
Top accounts researching Worldwide Clinical Trials
names withheld on the public pageThese are companies whose own people brought up Worldwide Clinical Trials unprompted, not accounts we guessed might be interested. We can't yet tell an implementation partner from a genuine buyer here, names unlock along with the buyer profile below.
3,463 companies · 13,523 people are researching Clinical Trials
Worldwide Clinical Trials's own team shows 36 signals on this topic. No one outside Worldwide Clinical Trials has been seen researching the company by name yet — so this is the market it sits in, not a list of its buyers.
- Drug Development1,165 cos · 3,772 people
- Artificial Intelligence129,094 cos · 649,540 people
Buyer profile
company size · seniorityCompany size and how senior the people involved are, the two things that decide whether this is a real deal. Competitor overlap isn't computed yet for this account.
Buying committee functions
Employee job titles (LinkedIn)Marketing — 4 people; Operations — 3 people; HR / Talent — 1 person; Leadership — 1 person; Sales — 1 person
What's been said
public posts mentioning Worldwide Clinical TrialsUp to 9 public excerpts naming Worldwide Clinical Trials from the past 365 days, across LinkedIn, Reddit, X, YouTube and other public sources.
*Inflammatory markers are moving from exploratory to primary* Two years ago, if a sponsor put hs-CRP or Pro-C3 into an obesity study, it was in the exploratory biomarker panel. Nobody expected the signal to matter for the primary story. That has changed faster than most teams expected. In the last twelve months, we've watched sponsors move inflammatory and fibrotic markers into the key secondary tier. A few have written them into primary endpoints for Phase IIb programs with a metabolic-steatotic indication. The reason is population overlap. A meaningful share of patients enrolled in obesity studies also carry MASLD, and most are undiagnosed at screening. The hepatic and inflammatory effects of GLP-1 therapy, favorable and unfavorable, are showing up in the data whether or not the protocol was designed to capture them. Sponsors who are not measuring are reading competitor papers and realizing they missed the story. Moving a biomarker from exploratory to primary means central lab validation, disciplined sample handling, a statistical analysis plan with real pre-specification, and enough retained samples to run confirmatory analyses. None of that is inexpensive. All of it is less expensive than running a second study. My read for metabolic sponsors: assume some fraction of your obesity population has silent inflammatory or hepatic disease. Design the biomarker panel so the answer is in your hands when the data reads out. More in the full paper next week. Alessandra Vignola Casey Ustick Sigrunn Blacoe Worldwide Clinical Trials Melanie Naghski MarieElena Cordisco #ObesityResearch #Biomarkers #ClinicalTrials
May 2026Always a highlight of the year! Looking forward to connecting and reconnecting with fellow researchers, catching up on the innovations, and continuing the collaborations that bring transformative treatments to patients everywhere 🧬 #ASGCT2026 Worldwide Clinical Trials
May 2026Join Worldwide Clinical Trials as a Senior Clinical Research Associate in Germany. Be part of work that truly changes lives through advancing clinical trials. Ready to make an impact? Explore the full role details here: https://bit.ly/4sSCs0h
Apr 2026Join Worldwide Clinical Trials as a Senior Clinical Research Associate in Japan. Be part of work that truly changes lives through advancing clinical trials. Ready to make an impact? Explore the full role details here: https://bit.ly/4dLN7Gs
Apr 2026Join Worldwide Clinical Trials as a #SiteActivation Specialist in Japan and be part of a compassionate, driven team with exciting growth opportunities. View the role details and apply today: https://bit.ly/4sQfVBD
Apr 2026Join Worldwide Clinical Trials as a Senior Clinical Research Associate in Japan. Be part of work that truly changes lives through advancing clinical trials. Ready to make an impact? Explore the full role details here: https://bit.ly/4czLOt1
Apr 2026Join Worldwide Clinical Trials as a Senior Clinical Research Associate in Japan. Be part of work that truly changes lives through advancing clinical trials. Ready to make an impact? Explore the full role details here: https://bit.ly/4mnAlAd
Apr 2026